FU-LV-Bevacizumab Regimen

Known as: 5FU/LV-Bevacizumab Regimen, FU-LV-Avastin Regimen 
A chemo-immunotherapy regimen consisting of fluorouracil, leucovorin, and bevacizumab used for the treatment of advanced-stage colorectal cancer.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2017
02419882017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Signal transducers and activators of transcription (STAT) play critical roles in development, proliferation, and immune defense… (More)
Is this relevant?
2015
2015
Hypoxia can stimulate (18)F-fluorodeoxyglucose ((18)F-FDG) uptake in cultured tumor cells. This study has investigated the effect… (More)
Is this relevant?
2014
2014
OBJECTIVE To compare the safety and efficacy of transurethral plasmakinetic resection of the prostate (PKRP) versus transvesical… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
We conducted a clinical trial of a seven-peptide vaccine in combination with tegafur-uracil/Leucovorin for advanced colorectal… (More)
Is this relevant?
2013
2013
Right ventricular (RV) and left ventricular (LV) myocardium differ in their pathophysiological response to pressure-overload… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2012
2012
Molecular mimetics of the caspase activator second mitochondria-derived activator of caspase (SMAC) are being investigated for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
PURPOSE Pigment epithelium-derived factor (PEDF), which has recently been shown to be the most potent inhibitor of angiogenesis… (More)
Is this relevant?
2005
2005
Direct in vivo administration of a lentiviral vaccine has been shown to transduce dendritic cells (DCs) in order to induce… (More)
Is this relevant?
1993
1993
PURPOSE A prospectively randomized trial was performed to determine whether the combination of fluorouracil (FU) plus leucovorin… (More)
Is this relevant?